CVS Health to Split into Two Companies
CVS Health announced on Wednesday its plan to split into two companies, separating its retail pharmacy operations from its insurance and pharmacy-benefit services, marking a significant unwinding of the healthcare conglomerate built through years of acquisitions.
The move comes amid growing scrutiny from lawmakers and regulators regarding vertically integrated healthcare companies like CVS. Years of industry consolidation have raised concerns about potential conflicts of interest, limited competition, and rising healthcare costs.
CVS aims to complete the separation in the first half of 2028, reversing its strategy of combining retail pharmacy, health insurance, and pharmacy-benefit management under one roof. The company has grown through a series of acquisitions, including the $78 billion purchase of health insurer Aetna in 2018.
Shares of CVS dropped over 10% in early trading on Wednesday, with Leerink Partners analyst Michael Cherny attributing the decline to deal-related uncertainty and broader volatility in healthcare stocks post-midterm elections.
Post-Split Leadership
Following the split, the healthcare solutions company will be temporarily named CVS Health, with David Joyner as CEO. Prem Shah, currently Group President, will become CEO of CVS Pharmacy.
Joyner stated, "From a position of strength, and a focus on the long term, we plan to create two focused companies to improve consumer engagement, affordability, and care coordination."
Industry Challenges
Health insurers and drugstores have faced challenges in recent years, with elevated medical costs and increased healthcare service usage leading to higher premiums and reduced benefits. CVS drugstores have also been impacted by competition from Amazon and a shift towards prescription delivery.
These challenges reflect the difficult economics of large US drugstore chains. Similar situations led Walgreens to sell its Boots pharmacy business and be acquired by Sycamore Partners last year.
Analyst Reactions and Financials
Analysts viewed the potential split positively, citing CVS’s Pharmacy and Consumer Wellness business returning to growth after years of underperformance. Morningstar analyst Julie Utterback noted, "Improving financial results probably helped with the timing of the move — better to move from a place of strength than a place of weakness."
The company also reported third-quarter results, beating earnings expectations with a per-share profit of $2.09. CVS raised its annual adjusted profit forecast but maintained a cautious outlook due to elevated medical cost trends and potential macro challenges.